Glasp vs Google DeepMind
Side-by-side trajectory, velocity, and editorial themes.
A web highlighter pivoting into YouTube creator tooling.
Glasp is repositioning from a generic web/PDF highlighter into a YouTube-centric summarization and creator tool, marketed under a paired Glasp & YouTube Summary branding. The substantive recent work is YouTube Channel Tracking (auto-import a creator's own videos with transcripts) and a creator partnership offering a free year of Pro in exchange for description links. A May 2026 pricing update consolidates the paid tier around YouTube summaries, PDF, audio transcription, and private highlights.
The reader-side highlighter is being de-emphasized in favor of YouTube as the primary content surface. The creator-side moves (channel tracking, free Pro in exchange for description backlinks) point at a flywheel: creators use Glasp on their own content, viewers use Glasp to summarize that content, viewer subscriptions monetize. A solitary backend-engineer job post implies the team behind this remains small.
Expect further YouTube-creator features (clip extraction, transcript editing, basic audience insights) and pricing tilted toward video-volume gates rather than feature gates.
DeepMind is repositioning Gemini as the substrate for scientific research, not just consumer AI.
DeepMind's recent output is dominated by Co-Scientist case studies and the formal launch of a 'Gemini for Science' suite, with applied research wins clustered around biology — aging, ALS, liver disease, infectious disease triggers. A second strand expands consumer-facing tools (Project Genie + Street View) for Google AI Ultra subscribers and pushes on content provenance. National partnership announcements (Singapore) round out the geopolitical surface.
The center of gravity is shifting from frontier model releases to vertical applications, particularly in life sciences. Co-Scientist appears to be moving from internal project to a packaged offering institutions can collaborate on. Consumer features and content authenticity work continue in parallel but feel secondary to the science push.
Expect a formal Co-Scientist productization announcement with institutional access tiers within the next quarter, and additional 'Gemini for X' verticals (likely materials science or drug discovery) to follow the science framing.
See more alternatives to Glasp →
See more alternatives to Google DeepMind →